| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/12/1995 | WO1995001435A1 A synthetic gene for d4 dopamine receptors |
| 01/12/1995 | WO1995001434A1 A truncated keratinocyte growth factor (kgf) having increased biological activity |
| 01/12/1995 | WO1995001433A1 Protein s deletion variants deficient in c4bp binding activity, but having apc cofactor activity, compositions and therapeutic methods |
| 01/12/1995 | WO1995001432A1 Novel polypeptide and dna coding for the same |
| 01/12/1995 | WO1995001431A1 Peptide family, designated as xenonins |
| 01/12/1995 | WO1995001430A1 Insect diuretic hormone receptor, preferably isolated from manduca sexta |
| 01/12/1995 | WO1995001429A1 Pharmaceutical compositions and their use, namely for the treatment of neurodegenerative diseases |
| 01/12/1995 | WO1995001428A1 Glycosylated and non-glycosylated bactericidal/permeability increasing proteins, and methods for producing same |
| 01/12/1995 | WO1995001427A1 Pro-urokinase mutants |
| 01/12/1995 | WO1995001424A1 Transformed mammalian cells capable of expressing cecropin b |
| 01/12/1995 | WO1995001422A1 Culture medium for recombinant yeasts |
| 01/12/1995 | WO1995001421A1 Expression system for production of recombinant proteins in yeast |
| 01/12/1995 | WO1995001376A1 Peptide inhibitors of mitogenesis and motogenesis |
| 01/12/1995 | WO1995001375A1 Inhibitor of collagen-stimulated platelet aggregation |
| 01/12/1995 | WO1995001374A1 Synthetic peptides of human papillomavirus |
| 01/12/1995 | WO1995001372A1 Peptidase resistant thrombin receptor peptide ligand |
| 01/12/1995 | WO1995001371A1 Novel peptide and antiplatelet aggregation containing the same |
| 01/12/1995 | WO1995001370A1 Higher order structure and binding of peptide nucleic acids |
| 01/12/1995 | WO1995001369A1 Double-stranded peptide nucleic acids |
| 01/12/1995 | WO1995001188A1 Polyvalent peptide pharmaceutical applications |
| 01/12/1995 | WO1995001182A1 THF-η2 ANALOGS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM |
| 01/12/1995 | WO1995001095A1 Transformed eukaryotic cells, and transposon-based transformation vectors |
| 01/12/1995 | WO1994025595A3 Cytolysin gene and gene product |
| 01/12/1995 | WO1994022911A3 A PROCESS AND INTERMEDIATE COMPOUNDS USEFUL FOR THE PREPARATION OF PLATELET GLYCOPROTEIN IIb/IIIa INHIBITORS CONTAINING Nα-METHYLARGININE |
| 01/12/1995 | WO1994019024A3 Technetium-99m labeled peptides for diagnostic imaging |
| 01/12/1995 | WO1994018335A3 Method of controlling plant pathogenic fungi |
| 01/12/1995 | WO1994018326A3 Regulatory gene for clavulanic acid biosynthesis |
| 01/12/1995 | CA2166488A1 Glycosylated and non-glycosylated bactericidal/permeability increasing proteins, and methods for producing same |
| 01/12/1995 | CA2166462A1 Double-stranded peptide nucleic acids |
| 01/12/1995 | CA2166461A1 Higher order structure and binding of peptide nucleic acids |
| 01/12/1995 | CA2166401A1 Helicobacter pylori haemagglutinin/protease protein, nucleic acid encoding therefor and antibodies specific thereto |
| 01/12/1995 | CA2166386A1 Immunoassay for soluble fibrin polymers |
| 01/12/1995 | CA2166333A1 Synthetic peptides of human papillomavirus |
| 01/12/1995 | CA2166298A1 Peptide family, designated as xenonins |
| 01/12/1995 | CA2166278A1 A truncated keratinocyte growth factor (kgf) having increased biological activity |
| 01/12/1995 | CA2165977A1 Pro-urokinase mutants |
| 01/12/1995 | CA2165666A1 Culture medium for recombinant yeasts |
| 01/12/1995 | CA2163432A1 A synthetic gene for d4 dopamine receptors |
| 01/12/1995 | CA2142713A1 Peptide inhibitors of mitogenesis and motogenesis |
| 01/11/1995 | EP0633318A1 Transduced fibroblasts and uses therefor |
| 01/11/1995 | EP0633313A1 Vaccine against lyme disease |
| 01/11/1995 | EP0633269A1 Variant luteinizing hormone encoding DNA |
| 01/11/1995 | EP0633268A2 MDC proteins and DNAs encoding the same |
| 01/11/1995 | EP0633028A1 Vaccine against lyme disease |
| 01/11/1995 | EP0632834A1 Microorganisms having attenuated invasiveness |
| 01/11/1995 | EP0632830A1 Processes for producing ribotoxins |
| 01/11/1995 | EP0632829A1 Thrombin receptor antagonists |
| 01/11/1995 | EP0632817A1 Neurotrophic factors having altered receptor binding specificities |
| 01/11/1995 | EP0632816A1 PEPTIDE SEQUENCE CAPABLE OF INDUCING A DELAYED-TYPE HYPERSENSITIVITY REACTION IN THE PRESENCE OF $i(MYCOBACTERIUM TUBERCULOSIS) COMPLEX LIVING BACTERIA, AND APPLICATIONS |
| 01/11/1995 | EP0632814A1 High molecular weight surface proteines of non-typeable haemophilus |
| 01/11/1995 | EP0632727A1 Conjugates formed from heat shock proteins and oligo- or polysaccharides |
| 01/11/1995 | EP0632722A1 A dna transporter system and method of use |
| 01/11/1995 | EP0598000A4 Method of diagnosing ovarian and endometrial cancer with monoclonal antibodies oxa and oxb. |
| 01/11/1995 | EP0592597A4 Novel mutagenesis methods and compositions. |
| 01/11/1995 | EP0362288B1 Expression of immunologically active proteins of human b-lymphotropic virus |
| 01/11/1995 | EP0207090B1 Monoclonal antibodies and antigens for human non-small cell lung carcinomas |
| 01/11/1995 | CN1027346C Wound healing and bone regeneration composition |
| 01/10/1995 | US5380873 Homobifunctional agents for coupling enzymes and the like to antibodies and the like |
| 01/10/1995 | US5380836 Nucleic acid encoding sodium channel protein |
| 01/10/1995 | US5380831 Synthetic insecticidal crystal protein gene |
| 01/10/1995 | US5380830 Molecular clones of bovine immunodeficiency-like virus |
| 01/10/1995 | US5380824 One-step, one-container method for the preparation of pyridoxylated hemoglobin |
| 01/10/1995 | US5380712 Truncated human serum albumin polypeptides as plasma expanding agents |
| 01/10/1995 | US5380710 Pharmaceutical compositions containing ACTH (1-24) for the therapy of shock conditions and respiratory and cardiocirculatory insufficiences |
| 01/10/1995 | US5380668 Compounds having the antigenicity of hCG |
| 01/10/1995 | US5380657 DNA segments and genetic vectors |
| 01/10/1995 | US5380656 Chymopapain and method of purifying it on an inhibitory dipeptide affinity column |
| 01/10/1995 | US5380655 Forming transformed Haemophilus influenzae cells used to make Haemophilus P2 antigen by transforming Haemophilus host cells with recombinant vector including DNA sequence encoding the antigen; selecting transformants expressing antigen; vector |
| 01/10/1995 | US5380653 Expression vectors and methods for intracellular protein production in bascillus |
| 01/10/1995 | US5380648 Method for the diagnosis of virulent bacteria |
| 01/10/1995 | US5380646 Thrombus detection using radiolabelled disintegrins |
| 01/10/1995 | CA1333892C Insulin-selective somatostatin analogs |
| 01/05/1995 | WO1995000852A2 A methodology for selecting superagonists, antagonists and superantagonists of hormones whose receptor complex includes gp 130 |
| 01/05/1995 | WO1995000851A1 Method for the diagnosis and analysis of tumours |
| 01/05/1995 | WO1995000849A1 Recombinant 170 kd subunit lectin of entamoeba histolytica and methods of use |
| 01/05/1995 | WO1995000848A1 Compositions and methods for anti-addictive narcotic analgesis acivity screening and treatments |
| 01/05/1995 | WO1995000846A1 Domain ligation strategy to engineer proteins with unusual architectures |
| 01/05/1995 | WO1995000670A1 Linear and branched peptides effective in diagnosing and detecting non-a, non-b hepatitis |
| 01/05/1995 | WO1995000659A1 Monoclonal antibodies against the alpha pdgf receptor and uses thereof |
| 01/05/1995 | WO1995000658A1 COMPOSITIONS AND DIAGNOSTIC METHODS USING MONOCLONAL ANTIBODIES AGAINST CD44v6 |
| 01/05/1995 | WO1995000657A1 Anti-sickling hemoglobin |
| 01/05/1995 | WO1995000654A1 Mesothelial cell gene therapy |
| 01/05/1995 | WO1995000651A1 Recombinant stratum corneum chymotryptic enzyme (scce) |
| 01/05/1995 | WO1995000649A1 Lipoprotein associated phospholipase a2, inhibitors thereof and use of the same in diagnosis and therapy |
| 01/05/1995 | WO1995000648A1 Nucleic acids of a novel hantavirus and reagents for detection and prevention of infection |
| 01/05/1995 | WO1995000647A1 Toxin gene from xenorhabdus nematophilus |
| 01/05/1995 | WO1995000646A1 Interleukin-3 (il-3) human/murine hybrid polypeptides |
| 01/05/1995 | WO1995000645A2 Process for producing relaxin |
| 01/05/1995 | WO1995000644A1 Vectors for genetically engineered cells that produce insulin in response to glucose |
| 01/05/1995 | WO1995000643A2 Human cell adhesion protein aamp-1 and uses thereof |
| 01/05/1995 | WO1995000642A1 Vertebrate apoptosis gene: compositions and methods |
| 01/05/1995 | WO1995000641A1 Lipopolysaccharide binding protein derivatives |
| 01/05/1995 | WO1995000640A1 Cloning and recombinant production of crf (corticotropin releasing factor) receptor(s) |
| 01/05/1995 | WO1995000639A1 Clostridium bifermentans dna fragment bearing genes coding for proteins linked to an insecticidal activity |
| 01/05/1995 | WO1995000633A2 Construction and use of synthetic constructs encoding syndecan |
| 01/05/1995 | WO1995000555A1 Regulation of site-specific recombination by site-specific recombinase/nuclear receptor fusion proteins |
| 01/05/1995 | WO1995000554A2 Totipotent hematopoietic stem cell receptors and their ligands |
| 01/05/1995 | WO1995000553A1 Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses |
| 01/05/1995 | WO1995000552A1 Prostaglandin receptor ep3 and dna encoding it |
| 01/05/1995 | WO1995000551A1 Prostaglandin receptor fp and dna encoding it |